Notice ID: 23f12c7c83c145d099b9e92aecc1d4e5Award NoticeAwarded
Research and Development of mAb114 for Ebola
Awarded on March 19, 2020. Full description on SAM.gov.
Awarded tounder 75A50120C00009 (source: SAM.gov award notice)• $150.7M
Overview
- Posted
- March 20, 2020
- Notice type
- Award Notice
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- ASPR ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
- Place of performance
- Coconut Grove, FL
- Last updated
- Sep 25, 2026
- Award date
- Mar 19, 2020
- Award amount (SAM.gov award notice)
- $150.7M
Identifiers
- Solicitation number
- 75A50120C00009
- Notice ID
- 23f12c7c83c145d099b9e92aecc1d4e5
- Award number (PIID)
- 75A50120C00009
Description
The Department of Health and Human Services Assistant Secretary for Preparedness and Response awarded a Sole Source contract to Ridgeback Biotherapeutics LP for the Research and Development of mAB114 for Ebola based on FAR 6.302 -1 "Only one Responsible Source and no other supplies or services will satisfy Agency requirements." The contract is a total estimated cost plus fixed fee (CPFF) type contract with a base period of total CPFF of $10,907,600.00. If all Options are exercised, the total contract CPFF will be $150,701,501.00. Please contact Ethan Mueller at Ethan.Mueller@HHS.Gov
Award Overview
Award Number
75A50120C00009
Award Amount (SAM.gov award notice)
$150.7M
Award Date
Mar 19, 2020
Awardee
Original Solicitation
Notice ID: 23f12c7c83c145d099b9e92aecc1d4e5
Posted Date: Mar 20, 2020
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $14.0MSigned Aug 15, 2025
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75A50120C00009- Awarded
This opportunity has been awarded.
- AwardedCurrentMar 20, 2020
Research and Development of mAb114 for Ebola
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50120C00009
Archive Date
Apr 19, 2020
Office Address
Washington, DC, 20201